Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
New HIV/AIDS study findings reported from B. Silbermann and co-authors
February 11th, 2009
"Long-term persistence of HIV vaccine-induced seropositivity in uninfected HIV vaccine recipients remains unknown," scientists in Paris, France report. "The duration of HIV humoral-induced responses was assessed in 72 volunteers who had received rgp160 and/or HIV recombinant canarypox virus constructs able to induce immune responses detectable using standard serological tests. Among the 43 rgp160 recipients, 94% and 83% remained HIV seropositive after 5 and 8 years of follow-up, respectively, while all the 29 volunteers who had received canarypox constructs alone were seronegative after 5 years," wrote B. Silbermann and colleagues. The researchers...
Source: Vaccine Weekly (2009-02-11)
|
